Synthesis, biological evaluation and structure-activity relationships of glycyrrhetinic acid derivatives as novel anti-hepatitis B virus agents. 2012

Li-Jun Wang, and Chang-An Geng, and Yun-Bao Ma, and Xiao-Yan Huang, and Jie Luo, and Hao Chen, and Xue-Mei Zhang, and Ji-Jun Chen
State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, PR China.

Fifty-seven derivatives of glycyrrhetinic acid (GA) were synthesized, and their anti-hepatitis B virus (HBV) activity was evaluated in HepG 2.2.15 cells. Among them, sixteen compounds showed greater anti-HBV activity than GA, especially, compounds 29, 32, 35, 41 exhibited significantly inhibitory activities against HBV DNA replication with IC(50) values of 5.71, 5.36, 8.90 and 9.08 μM, respectively. The structure-activity relationships (SARs) of GA derivatives were discussed for exploring novel anti-HBV agents.

UI MeSH Term Description Entries
D004261 DNA Replication The process by which a DNA molecule is duplicated. Autonomous Replication,Replication, Autonomous,Autonomous Replications,DNA Replications,Replication, DNA,Replications, Autonomous,Replications, DNA
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D006034 Glycyrrhetinic Acid An oleanolic acid from GLYCYRRHIZA that has some antiallergic, antibacterial, and antiviral properties. It is used topically for allergic or infectious skin inflammation and orally for its aldosterone effects in electrolyte regulation. Enoxolone,Glycyrrhetic Acid,Rhetinic Acid,Uralenic Acid,Arthrodont,Glyciram,Glycyram,Jintan,Po 12,12, Po,Acid, Glycyrrhetic,Acid, Glycyrrhetinic,Acid, Rhetinic,Acid, Uralenic
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications

Related Publications

Li-Jun Wang, and Chang-An Geng, and Yun-Bao Ma, and Xiao-Yan Huang, and Jie Luo, and Hao Chen, and Xue-Mei Zhang, and Ji-Jun Chen
January 2017, MedChemComm,
Li-Jun Wang, and Chang-An Geng, and Yun-Bao Ma, and Xiao-Yan Huang, and Jie Luo, and Hao Chen, and Xue-Mei Zhang, and Ji-Jun Chen
September 2019, European journal of medicinal chemistry,
Li-Jun Wang, and Chang-An Geng, and Yun-Bao Ma, and Xiao-Yan Huang, and Jie Luo, and Hao Chen, and Xue-Mei Zhang, and Ji-Jun Chen
March 2011, European journal of medicinal chemistry,
Li-Jun Wang, and Chang-An Geng, and Yun-Bao Ma, and Xiao-Yan Huang, and Jie Luo, and Hao Chen, and Xue-Mei Zhang, and Ji-Jun Chen
February 2014, Molecules (Basel, Switzerland),
Li-Jun Wang, and Chang-An Geng, and Yun-Bao Ma, and Xiao-Yan Huang, and Jie Luo, and Hao Chen, and Xue-Mei Zhang, and Ji-Jun Chen
April 1985, Journal of medicinal chemistry,
Li-Jun Wang, and Chang-An Geng, and Yun-Bao Ma, and Xiao-Yan Huang, and Jie Luo, and Hao Chen, and Xue-Mei Zhang, and Ji-Jun Chen
November 2010, Bioorganic & medicinal chemistry letters,
Li-Jun Wang, and Chang-An Geng, and Yun-Bao Ma, and Xiao-Yan Huang, and Jie Luo, and Hao Chen, and Xue-Mei Zhang, and Ji-Jun Chen
September 2013, Bioorganic & medicinal chemistry letters,
Li-Jun Wang, and Chang-An Geng, and Yun-Bao Ma, and Xiao-Yan Huang, and Jie Luo, and Hao Chen, and Xue-Mei Zhang, and Ji-Jun Chen
July 2020, Molecules (Basel, Switzerland),
Li-Jun Wang, and Chang-An Geng, and Yun-Bao Ma, and Xiao-Yan Huang, and Jie Luo, and Hao Chen, and Xue-Mei Zhang, and Ji-Jun Chen
February 2021, Bioorganic & medicinal chemistry,
Li-Jun Wang, and Chang-An Geng, and Yun-Bao Ma, and Xiao-Yan Huang, and Jie Luo, and Hao Chen, and Xue-Mei Zhang, and Ji-Jun Chen
May 2015, European journal of medicinal chemistry,
Copied contents to your clipboard!